Key Highlights: Implications: This curbs aggressive GLP-1 marketing (e.g., Ozempic/Wegovy), protecting India’s $115M diabetes/obesity segment from off-label hype amid 101M diabetics....
Home / Obesity Drugs
Browsing Tag: Obesity Drugs
Featured Posts
1
Top 10 Indian BioPharma Companies of 2026
July 28, 20262
3
Sun Pharmaceutical Industries
July 27, 2026